Europe PMCopen access
Plasma proteome profiling identifies XPNPEP3 as a novel biomarker associated with metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus
Type 2 diabetes mellitus, Biomarkers, Plasma Proteomics, Xpnpep3, Metabolic Dysfunction-associated Steatotic Liver Disease
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 120093
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.